Showing results (811-820 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|April 16, 2021
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family MembersMairene Coto-Llerena, Nadia Tosti, Stephanie Taha-Mehlitz, et al.
Hepatology Communications|April 16, 2021
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular CarcinomaNorifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, et al.
Hepatology Communications|August 18, 2025
PolyIC as an adjuvant outperforms anti-VEGF in combination with anti-PD-L1 therapy in mouse liver tumor modelsYichun Ji, Li-Chun Lu, Hao Zhuang, et al.
Hepatology Communications|August 18, 2025
Bioartificial liver: Where lies the path ahead-A reviewQi Jiang, Yuanshuai Su, Xiaoyan Cao, et al.
Hepatology Communications|October 21, 2025
The impact of food insecurity on chronic liver disease: A systematic review of the literatureLaila M Elias, Jordy E Agins, David S Goldberg, et al.
Hepatology Communications|June 27, 2025
Feasible and acceptable social drivers of health screening among patients with chronic liver diseaseRebecca G Kim, April Ballantyne, Rachel R Codden, et al.
Hepatology Communications|June 19, 2025
Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020Phuc Le, Eda Kaya, Anh Phan, et al.
Hepatology Communications|June 19, 2025
Semaglutide versus other GLP-1 receptor agonists in patients with MASLDChia-Chih Kuo, Chun-Hsien Li, Min-Hsiang Chuang, et al.
Hepatology Communications|June 9, 2025
Blood bacterial DNA signatures in a prospective cohort of patients with MASLD cirrhosisSuet-Ying Kwan, Lillian I Dolapchiev, Caren I Sanchez, et al.
Hepatology Communications|June 9, 2025
A phase 2 trial of short-term intravenous N-acetylcysteine in biliary atresia after Kasai portoenterostomySanjiv Harpavat, Kristin A Borovsky, Michael E Scheurer, et al.
Pageof 179